Clinical Trials on Somatic Mutation Breast Cancer (BRCA2) in Colombia
Total 610 results
-
AstraZenecaCompletedHER2-ve Metastatic Breast Cancer | Germline BRCA1/2 Mutations | Somatic BRCA1/2 MutationsItaly, Spain, Poland, Taiwan, Canada, France, Germany, Korea, Republic of, Hungary, Japan, Russian Federation, Turkey, United Kingdom, United States, Bulgaria
-
Georgetown UniversityCompletedPancreatic Cancer | Breast Neoplasm | BRCA1 Mutation | BRCA2 Mutation | Prostate CarcinomaUnited States
-
Georgetown UniversityGeorge Washington UniversityEnrolling by invitation
-
AstraZenecaMerck Sharp & Dohme LLC; Myriad Genetic Laboratories, Inc.Active, not recruitingBreast Cancer Metastatic | BRCA 1 Gene Mutation | BRCA 2 Gene MutationItaly, Spain, United States, Czechia, Romania, France, Korea, Republic of, United Kingdom, Hungary, Japan, Peru, Poland, Russian Federation, Turkey, China, Taiwan, Bulgaria, Switzerland, Mexico
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Austrian Breast & Colorectal Cancer Study...RecruitingNeoplasms | Breast Cancer | Breast Neoplasms | Breast Diseases | Breast Carcinoma | BRCA1 MutationUnited States
-
Georgetown UniversityNational Cancer Institute (NCI); National Human Genome Research Institute (NHGRI)CompletedBreast Cancer | Hereditary Breast/Ovarian Cancer (brca1, brca2)United States
-
Tesaro, Inc.European Organisation for Research and Treatment of Cancer - EORTC; Breast... and other collaboratorsTerminatedOvarian Neoplasms | BRCA1 Gene Mutation | BRCA2 Gene Mutation | Neoplasms, Breast | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | Carcinoma of BreastUnited States, Spain, Belgium, Israel, United Kingdom, Italy, Poland, Canada, Hungary, Netherlands, France, Portugal, Greece, Iceland
-
VA Office of Research and DevelopmentRecruitingMetastatic Castrate Resistant Prostate Cancer | BARD1, BRCA1, BRCA2, BRIP1, CHEK1, FANCL, PALB2 | RAD51B, RAD51C, RAD51D, or RAD54L MutationsUnited States
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedBRCA1 Gene Mutation | BRCA2 Gene Mutation | Recurrent Squamous Cell Lung Carcinoma | Stage IV Squamous Cell Lung Carcinoma AJCC v7 | BRIP1 Gene Mutation | PALB2 Gene Mutation | ATM Gene Mutation | ATR Gene Mutation | CHEK2 Gene Mutation | NBN Gene Mutation | RAD51 Gene Mutation | CHEK1 Gene Mutation | FANCA Gene... and other conditionsUnited States, Canada
-
Puma Biotechnology, Inc.TerminatedSolid Tumors Harboring Somatic HER2 or EGFR Exon 18 MutationsFrance, United States, Spain, Belgium, United Kingdom, Serbia, Australia, Israel, Canada, Denmark, Ireland, Italy, Korea, Republic of
-
Universidad Nacional de ColombiaFundación Salud de los AndesNot yet recruiting
-
Universidad Nacional de ColombiaInstituto Colombiano para el Desarrollo de la Ciencia y la Tecnología (COLCIENCIAS) and other collaboratorsCompleted
-
National Cancer Institute (NCI)TerminatedMale Breast Cancer | Stage IV Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative Breast CancerCanada
-
Fundación Salud de los AndesInstituto Colombiano para el Desarrollo de la Ciencia y la Tecnología (COLCIENCIAS) and other collaboratorsCompleted
-
Universidad Nacional de ColombiaFundación Salud de los AndesCompletedBreast Cancer | Triple Negative Breast CancerColombia
-
xCuresCancer CommonsAvailableExpanded Access to Ulixertinib (BVD-523) in Patients With Advanced MAPK Pathway-Altered MalignanciesMelanoma | Head and Neck Cancer | Glioblastoma | Hepatocellular Carcinoma | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Esophageal Cancer | Small Bowel Cancer | Ovarian Cancer | Non Small Cell Lung Cancer | Cholangiocarcinoma | Bladder Cancer | Thyroid Cancer | ERK Mutation | MAPK Gene Mutation | KRAS Activating... and other conditionsUnited States
-
University Health Network, TorontoBayer; AstraZeneca; Amgen; AnHeart Therapeutics Inc.; Applied Health Research Centre and other collaboratorsRecruitingCancer | Malignancies Multiple | Malignant Solid Tumor | Cancer, Therapy-Related | Molecular Sequence Variation | Genetic Alteration | Gene Fusion | Receptor Tyrosine Kinase Gene Mutation | RTK Family Gene Mutation | Ras (Kras or Nras) Gene MutationCanada
-
British Columbia Cancer AgencyActive, not recruitingEarly Stage Breast CancerCanada
-
Grupo de investigación C.E.RHematooncologos S.A.Active, not recruiting
-
Olga Lucia SarmientoNational Cancer Institute (NCI); University of California, Los Angeles; National... and other collaboratorsCompletedBreast Cancer | Physical InactivityColombia
-
National Cancer Institute (NCI)CompletedStage IV Breast Cancer | Recurrent Breast CancerUnited States
-
University Health Network, TorontoActive, not recruitingBreast Cancer | Advanced Solid CancersCanada
-
Georgetown UniversityPfizerActive, not recruitingMetastatic Breast Cancer | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | Hormone Receptor Positive Breast CancerUnited States
-
Hospital Universitario San IgnacioPontificia Universidad JaverianaRecruitingQuality of Life | Breast Cancer | Tumor, BreastColombia
-
British Columbia Cancer AgencyCanadian Cancer Society (CCS); NanoString Technologies, Inc.Active, not recruitingBreast Cancer Female | Hormone Receptor Positive TumorCanada
-
Georgetown UniversityUnknownBreast Cancer FemaleUnited States
-
Canadian Cancer Trials GroupAstraZenecaCompletedMetastatic Breast CancerCanada
-
George Washington UniversityWithdrawnTriple Negative Breast CancerUnited States
-
Jose Pablo LeoneEli Lilly and Company; Translational Breast Cancer Research Consortium (TBCRC)RecruitingMale Breast Cancer | Hormone Receptor-positive Breast Cancer | Hormone Receptor Negative Breast CarcinomaUnited States
-
Zetagen Therapeutics, IncRecruitingMetastatic Breast Cancer in the SpineCanada
-
Medstar Health Research InstituteGenentech, Inc.TerminatedHER-2 Positive Metastatic Breast CancerUnited States
-
National Cancer Institute (NCI)CompletedBreast Cancer | Stage IV Breast Cancer | Recurrent Breast CancerCanada
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)Active, not recruitingStage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8 | Lung Non-Small Cell Squamous Carcinoma | Recurrent Lung Non-Small Cell Carcinoma | Deleterious BRCA1 Gene Mutation | Deleterious BRCA2 Gene Mutation | Recurrent Lung Adenocarcinoma | Loss of Heterozygosity | Recurrent... and other conditionsUnited States
-
Canadian Cancer Trials GroupUniversity Health Network, Toronto; AstraZenecaActive, not recruitingBreast CancerCanada
-
Georgetown UniversityTerminatedBreast Cancer | Neoplasms, Breast | Cancer of the BreastUnited States
-
University of British ColumbiaCanadian Cancer Society (CCS)Completed
-
University of Missouri-ColumbiaUniversity of Missouri, Kansas City; University of Missouri, St. LouisCompleted
-
University of British ColumbiaBritish Columbia Cancer AgencyCompleted
-
British Columbia Cancer AgencyBC Cancer FoundationUnknown
-
Centro de Tratamiento e Investigación sobre Cáncer...Not yet recruitingNon Small Cell Lung Cancer | EGF-R Positive Non-Small Cell Lung Cancer | EGFR Exon 19 Deletion | EGFR G719X | EGFR Exon 21 MutationColombia
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI); Genentech, Inc.Active, not recruitingTriple Negative Breast Cancer | Invasive Breast Cancer | Stage IV Breast Cancer | HER2 NegativeUnited States
-
Medstar Health Research InstituteGenentech, Inc.CompletedLeft Ventricular Function Systolic Dysfunction | HER2 Positive Breast CancerUnited States
-
Georgetown UniversityBristol-Myers SquibbActive, not recruitingTriple Negative Breast CancerUnited States
-
Canadian Cancer Trials GroupOncolytics BiotechCompletedMetastatic Breast CancerCanada
-
University of Missouri-ColumbiaCompletedBreast Cancer FemaleUnited States
-
Georgetown UniversityTyme, IncTerminatedBreast Cancer | Metastatic Breast Cancer | Hormone Receptor Positive Breast CarcinomaUnited States
-
University of South CarolinaNational Cancer Institute (NCI); American Cancer Society, Inc.CompletedBreast CancerUnited States
-
University of South CarolinaCompletedBreast CancerUnited States
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Bayer; Novartis Pharmaceuticals; Rutgers Cancer...CompletedMetastatic Breast CancerUnited States